Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

National Center for Research Resources (NCRR)

ClinicalTrials.gov lists National Center for Research Resources (NCRR) as lead sponsor of 265 trials. It has 123 approved assets.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

38 0 1990 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers National Center for Research Resources (NCRR): 265 lead-sponsored trials and 0 legal-entity registrations.

Get the National Center for Research Resources (NCRR) report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (398)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Rare Diseases 164
Diabetes Mellitus 51
Premature Birth 38
Obesity 31
Diabetes Mellitus, Type 2 20

Showing 5 of 398 disease areas.

Start your 14-day trial Email me the first 50 disease areas as a PDF

Trials by start year as sponsor or collaborator (28)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2025 1
2018 1
2015 1
2014 7
2013 4
2012 15
2011 19
2010 25
2009 30
2008 18

Showing 10 of 28 years.

Start your 14-day trial Email me all 28 years as a PDF

Recruitment duration, a model prediction: none of the 265 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (123)

Shown in this order: max phase first.

Approved assets
Drug Trials
Epoprostenol 1
METHYLPHENIDATE 1
ZINC 1
Vitamin E 1
Dehydroepiandrosterone 4

Showing 5 of 123 approved assets.

Start your 14-day trial Email me the first 50 approved assets as a PDF

Journals published in (284)

Shown in this order: most published in first.

Journals published in
Journal Publications
Pediatrics 67
The Journal of pediatrics 45
Diabetes care 34
The New England journal of medicine 27
The Journal of clinical endocrinology and metabolism 21

Showing 5 of 284 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

Organization relationships (28)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
NICHD Neonatal Research Network Co sponsors trial with 22
University of North Carolina Co sponsors trial with 6
Office of Rare Diseases (ORD) Co sponsors trial with 5
Ohio State University Co sponsors trial with 4
University of Massachusetts, Worcester Co sponsors trial with 2

Showing 5 of 28 relationships.

Start your 14-day trial Email me all 28 relationships as a PDF

Latest dated events (444)

Shown in this order: newest first.

Latest dated events
Date Event Source
2025-04-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2018-01-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2015-11 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2014-12 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2014-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 444 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarker capability evidence (470)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ABO Trial collaborator Named in trial inclusion criteria
ACE Trial collaborator Named in trial inclusion criteria
ACE Trial collaborator Named in trial inclusion criteria
AFP Trial collaborator Named in trial inclusion criteria
AGA Trial collaborator Named in trial inclusion criteria

Showing 5 of 470 evidence rows.

Start your 14-day trial Email me the first 50 evidence rows as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.